{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:44:51Z","timestamp":1788529491313,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017R1A2B4009963"],"award-info":[{"award-number":["NRF-2017R1A2B4009963"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Institutue of Oriental Medicine","award":["K18182"],"award-info":[{"award-number":["K18182"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12035-018-1194-6","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T17:35:58Z","timestamp":1532108158000},"page":"2408-2423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acupuncture Alleviates Levodopa-Induced Dyskinesia via Melanin-Concentrating Hormone in Pitx3-Deficient aphakia and 6-Hydroxydopamine-Lesioned Mice"],"prefix":"10.1007","volume":"56","author":[{"given":"Yu-Kang","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah-Reum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanseul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsang","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sora","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Hee","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongpil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hi-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"issue":"6","key":"1194_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909","journal-title":"Neuron"},{"issue":"15","key":"1194_CR2","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25(15):2649\u20132653. \n                    https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord"},{"issue":"7","key":"1194_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1515\/revneuro-2016-0009","volume":"27","author":"JR Phillips","year":"2016","unstructured":"Phillips JR, Eissa AM, Hewedi DH, Jahanshahi M, El-Gamal M, Keri S, Moustafa AA (2016) Neural substrates and potential treatments for levodopa-induced dyskinesias in Parkinson\u2019s disease. Rev Neurosci 27(7):729\u2013738. \n                    https:\/\/doi.org\/10.1515\/revneuro-2016-0009","journal-title":"Rev Neurosci"},{"issue":"9","key":"1194_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.parkreldis.2014.06.001","volume":"20","author":"MC Hechtner","year":"2014","unstructured":"Hechtner MC, Vogt T, Zollner Y, Schroder S, Sauer JB, Binder H, Singer S, Mikolajczyk R (2014) Quality of life in Parkinson\u2019s disease patients with motor fluctuations and dyskinesias in five European countries. Parkinsonism Relat Disord 20(9):969\u2013974. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2014.06.001","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"1194_CR5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s40265-016-0566-3","volume":"76","author":"D Vijayakumar","year":"2016","unstructured":"Vijayakumar D, Jankovic J (2016) Drug-induced dyskinesia, part 1: treatment of levodopa-induced dyskinesia. Drugs 76(7):759\u2013777. \n                    https:\/\/doi.org\/10.1007\/s40265-016-0566-3","journal-title":"Drugs"},{"issue":"34","key":"1194_CR6","doi-asserted-by":"publisher","first-page":"57316","DOI":"10.18632\/oncotarget.17622","volume":"8","author":"M Kong","year":"2017","unstructured":"Kong M, Ba M, Ren C, Yu L, Dong S, Yu G, Liang H (2017) An updated meta-analysis of amantadine for treating dyskinesia in Parkinson\u2019s disease. Oncotarget 8(34):57316\u201357326. \n                    https:\/\/doi.org\/10.18632\/oncotarget.17622","journal-title":"Oncotarget"},{"issue":"2","key":"1194_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/mdc3.12266","volume":"3","author":"TK Yaw","year":"2016","unstructured":"Yaw TK, Fox SH, Lang AE (2016) Clozapine in parkinsonian rest tremor: a review of outcomes, adverse reactions, and possible mechanisms of action. Mov Disord Clin Pract 3(2):116\u2013124","journal-title":"Mov Disord Clin Pract"},{"issue":"12","key":"1194_CR8","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/mds.22673","volume":"24","author":"Y Chae","year":"2009","unstructured":"Chae Y, Lee H, Kim H, Kim CH, Chang DI, Kim KM, Park HJ (2009) Parsing brain activity associated with acupuncture treatment in Parkinson\u2019s diseases. Mov Disord 24(12):1794\u20131802. \n                    https:\/\/doi.org\/10.1002\/mds.22673","journal-title":"Mov Disord"},{"issue":"3","key":"1194_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1142\/S0192415X15500263","volume":"43","author":"FP Chen","year":"2015","unstructured":"Chen FP, Chang CM, Shiu JH, Chiu JH, Wu TP, Yang JL, Kung YY, Chen FJ et al (2015) A clinical study of integrating acupuncture and Western medicine in treating patients with Parkinson\u2019s disease. Am J Chin Med 43(3):407\u2013423. \n                    https:\/\/doi.org\/10.1142\/S0192415X15500263","journal-title":"Am J Chin Med"},{"key":"1194_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainres.2013.11.028","volume":"1544","author":"SN Kim","year":"2014","unstructured":"Kim SN, Doo AR, Park JY, Choo HJ, Shim I, Park JJ, Chae Y, Lee B et al (2014) Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson\u2019s disease-induced neurochemical imbalance. Brain Res 1544:33\u201344. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2013.11.028","journal-title":"Brain Res"},{"issue":"2","key":"1194_CR11","doi-asserted-by":"publisher","first-page":"e56736","DOI":"10.1371\/journal.pone.0056736","volume":"8","author":"JH Kim","year":"2013","unstructured":"Kim JH, Choi KH, Jang YJ, Bae SS, Shin BC, Choi BT, Shin HK (2013) Electroacupuncture acutely improves cerebral blood flow and attenuates moderate ischemic injury via an endothelial mechanism in mice. PLoS One 8(2):e56736. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0056736","journal-title":"PLoS One"},{"issue":"12","key":"1194_CR12","doi-asserted-by":"publisher","first-page":"e114057","DOI":"10.1371\/journal.pone.0114057","volume":"9","author":"L Li","year":"2014","unstructured":"Li L, Zhang H, Meng SQ, Qian HZ (2014) An updated meta-analysis of the efficacy and safety of acupuncture treatment for cerebral infarction. PLoS One 9(12):e114057. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0114057","journal-title":"PLoS One"},{"issue":"1","key":"1194_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jams.2016.12.007","volume":"10","author":"FH Aroxa","year":"2017","unstructured":"Aroxa FH, Gondim IT, Santos EL, Coriolano MD, Asano AG, Asano NM (2017) Acupuncture as adjuvant therapy for sleep disorders in Parkinson\u2019s disease. J Acupunct Meridian Stud 10(1):33\u201338. \n                    https:\/\/doi.org\/10.1016\/j.jams.2016.12.007","journal-title":"J Acupunct Meridian Stud"},{"issue":"6","key":"1194_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3937\/kampomed.62.691","volume":"62","author":"T Mizushima","year":"2011","unstructured":"Mizushima T (2011) Treatment results between matched pair of L-dopa medication treatment and acupuncture treatment combination on Parkinson disease\u2014the randomized controlled trial between 2 groups. Kampo Med 62(6):691\u2013694","journal-title":"Kampo Med"},{"key":"1194_CR15","doi-asserted-by":"publisher","first-page":"692795","DOI":"10.1155\/2015\/692795","volume":"2015","author":"F Wang","year":"2015","unstructured":"Wang F, Sun L, Zhang XZ, Jia J, Liu Z, Huang XY, Yu SY, Zuo LJ et al (2015) Effect and potential mechanism of electroacupuncture add-on treatment in patients with Parkinson\u2019s disease. Evid Based Complement Alternat Med 2015:692795. \n                    https:\/\/doi.org\/10.1155\/2015\/692795","journal-title":"Evid Based Complement Alternat Med"},{"issue":"11","key":"1194_CR16","doi-asserted-by":"publisher","first-page":"e27566","DOI":"10.1371\/journal.pone.0027566","volume":"6","author":"SN Kim","year":"2011","unstructured":"Kim SN, Doo AR, Park JY, Bae H, Chae Y, Shim I, Lee H, Moon W et al (2011) Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson\u2019s disease. PLoS One 6(11):e27566. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0027566","journal-title":"PLoS One"},{"issue":"3","key":"1194_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpain.2012.11.011","volume":"14","author":"Y Chae","year":"2013","unstructured":"Chae Y, Chang DS, Lee SH, Jung WM, Lee IS, Jackson S, Kong J, Lee H et al (2013) Inserting needles into the body: a meta-analysis of brain activity associated with acupuncture needle stimulation. J Pain 14(3):215\u2013222. \n                    https:\/\/doi.org\/10.1016\/j.jpain.2012.11.011","journal-title":"J Pain"},{"issue":"2","key":"1194_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2008.11.048","volume":"450","author":"Y Chae","year":"2009","unstructured":"Chae Y, Lee H, Kim H, Sohn H, Park JH, Park HJ (2009) The neural substrates of verum acupuncture compared to non-penetrating placebo needle: an fMRI study. Neurosci Lett 450(2):80\u201384. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2008.11.048","journal-title":"Neurosci Lett"},{"issue":"1","key":"1194_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(02)00551-7","volume":"329","author":"GS Choi","year":"2002","unstructured":"Choi GS, Oha SD, Han JB, Bae HS, Cho YW, Yun YS, Lee WK, Ahn HJ et al (2002) Modulation of natural killer cell activity affected by electroacupuncture through lateral hypothalamic area in rats. Neurosci Lett 329(1):1\u20134","journal-title":"Neurosci Lett"},{"issue":"2","key":"1194_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0304-3940(01)01952-8","volume":"307","author":"JC Hsieh","year":"2001","unstructured":"Hsieh JC, Tu CH, Chen FP, Chen MC, Yeh TC, Cheng HC, Wu YT, Liu RS et al (2001) Activation of the hypothalamus characterizes the acupuncture stimulation at the analgesic point in human: a positron emission tomography study. Neurosci Lett 307(2):105\u2013108","journal-title":"Neurosci Lett"},{"issue":"3","key":"1194_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neulet.2007.04.078","volume":"421","author":"S Liu","year":"2007","unstructured":"Liu S, Zhou W, Ruan X, Li R, Lee T, Weng X, Hu J, Yang G (2007) Activation of the hypothalamus characterizes the response to acupuncture stimulation in heroin addicts. Neurosci Lett 421(3):203\u2013208. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2007.04.078","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"1194_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0361-9230(93)90039-E","volume":"30","author":"C Takeshige","year":"1993","unstructured":"Takeshige C, Oka K, Mizuno T, Hisamitsu T, Luo CP, Kobori M, Mera H, Fang TQ (1993) The acupuncture point and its connecting central pathway for producing acupuncture analgesia. Brain Res Bull 30(1\u20132):53\u201367","journal-title":"Brain Res Bull"},{"issue":"9","key":"1194_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3969\/j.issn.1673-5374.2013.09.005","volume":"8","author":"Z Yu","year":"2013","unstructured":"Yu Z, Xia Y, Ju C, Shao Q, Mao Z, Gu Y, Xu B (2013) Electroacupuncture regulates glucose-inhibited neurons in treatment of simple obesity. Neural Regen Res 8(9):809\u2013816. \n                    https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.09.005","journal-title":"Neural Regen Res"},{"key":"1194_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.01.018","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"1194_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.20834","volume":"59","author":"JW Langston","year":"2006","unstructured":"Langston JW (2006) The Parkinson\u2019s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59(4):591\u2013596. \n                    https:\/\/doi.org\/10.1002\/ana.20834","journal-title":"Ann Neurol"},{"issue":"7","key":"1194_CR26","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mds.26592","volume":"31","author":"DP Breen","year":"2016","unstructured":"Breen DP, Nombela C, Vuono R, Jones PS, Fisher K, Burn DJ, Brooks DJ, Reddy AB et al (2016) Hypothalamic volume loss is associated with reduced melatonin output in Parkinson\u2019s disease. Mov Disord 31(7):1062\u20131066. \n                    https:\/\/doi.org\/10.1002\/mds.26592","journal-title":"Mov Disord"},{"issue":"23","key":"1194_CR27","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1212\/WNL.0000000000003396","volume":"87","author":"G Pagano","year":"2016","unstructured":"Pagano G, Molloy S, Bain PG, Rabiner EA, Chaudhuri KR, Brooks DJ, Pavese N (2016) Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease. Neurology 87(23):2451\u20132456. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003396","journal-title":"Neurology"},{"issue":"10","key":"1194_CR28","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1007\/s12035-016-0258-8","volume":"54","author":"Ji-Yeun Park","year":"2016","unstructured":"Park JY, Kim SN, Yoo J, Jang J, Lee A, Oh JY, Kim H, Oh ST et al (2016) Novel neuroprotective effects of melanin-concentrating hormone in Parkinson\u2019s disease. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-016-0258-8","journal-title":"Molecular Neurobiology"},{"key":"1194_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nbd.2015.01.003","volume":"76","author":"SA Lim","year":"2015","unstructured":"Lim SA, Xia R, Ding Y, Won L, Ray WJ, Hitchcock SA, McGehee DS, Kang UJ (2015) Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia. Neurobiol Dis 76:67\u201376. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2015.01.003","journal-title":"Neurobiol Dis"},{"issue":"80","key":"1194_CR30","doi-asserted-by":"publisher","first-page":"ra36","DOI":"10.1126\/scisignal.2000308","volume":"2","author":"E Santini","year":"2009","unstructured":"Santini E, Heiman M, Greengard P, Valjent E, Fisone G (2009) Inhibition of mTOR signaling in Parkinson\u2019s disease prevents L-DOPA-induced dyskinesia. Sci Signal 2(80):ra36. \n                    https:\/\/doi.org\/10.1126\/scisignal.2000308","journal-title":"Sci Signal"},{"issue":"1","key":"1194_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nbd.2007.03.013","volume":"27","author":"Y Ding","year":"2007","unstructured":"Ding Y, Restrepo J, Won L, Hwang DY, Kim KS, Kang UJ (2007) Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson\u2019s disease. Neurobiol Dis 27(1):11\u201323. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2007.03.013","journal-title":"Neurobiol Dis"},{"key":"1194_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nbd.2014.09.010","volume":"73","author":"O Solis","year":"2015","unstructured":"Solis O, Espadas I, Del-Bel EA, Moratalla R (2015) Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-\/-) aphakia mice. Neurobiol Dis 73:49\u201359. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2014.09.010","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1194_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","volume":"16","author":"M Lundblad","year":"2004","unstructured":"Lundblad M, Picconi B, Lindgren H, Cenci MA (2004) A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 16(1):110\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2004.01.007","journal-title":"Neurobiol Dis"},{"key":"1194_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.reprotox.2013.10.003","volume":"42","author":"X Wang","year":"2013","unstructured":"Wang X, Wang M, Dong W, Li Y, Zheng X, Piao F, Li S (2013) Subchronic exposure to lead acetate inhibits spermatogenesis and downregulates the expression of Ddx3y in testis of mice. Reprod Toxicol 42:242\u2013250. \n                    https:\/\/doi.org\/10.1016\/j.reprotox.2013.10.003","journal-title":"Reprod Toxicol"},{"issue":"1","key":"1194_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12906-017-1731-2","volume":"17","author":"S Ahn","year":"2017","unstructured":"Ahn S, Song TJ, Park SU, Jeon S, Kim J, Oh JY, Jang J, Hong S et al (2017) Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson\u2019s disease. BMC Complement Altern Med 17(1):220. \n                    https:\/\/doi.org\/10.1186\/s12906-017-1731-2","journal-title":"BMC Complement Altern Med"},{"issue":"12","key":"1194_CR36","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s00213-016-4285-y","volume":"233","author":"C Karlsson","year":"2016","unstructured":"Karlsson C, Rehman F, Damdazic R, Atkins AL, Schank JR, Gehlert DR, Steensland P, Thorsell A et al (2016) The melanin-concentrating hormone-1 receptor modulates alcohol-induced reward and DARPP-32 phosphorylation. Psychopharmacology 233(12):2355\u20132363. \n                    https:\/\/doi.org\/10.1007\/s00213-016-4285-y","journal-title":"Psychopharmacology"},{"issue":"4","key":"1194_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.smrv.2012.10.002","volume":"17","author":"JM Monti","year":"2013","unstructured":"Monti JM, Torterolo P, Lagos P (2013) Melanin-concentrating hormone control of sleep-wake behavior. Sleep Med Rev 17(4):293\u2013298. \n                    https:\/\/doi.org\/10.1016\/j.smrv.2012.10.002","journal-title":"Sleep Med Rev"},{"issue":"Suppl 1","key":"1194_CR38","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1038\/ijosup.2014.9","volume":"4","author":"F Presse","year":"2014","unstructured":"Presse F, Conductier G, Rovere C, Nahon JL (2014) The melanin-concentrating hormone receptors: neuronal and non-neuronal functions. Int J Obes Suppl 4(Suppl 1):S31\u2013S36. \n                    https:\/\/doi.org\/10.1038\/ijosup.2014.9","journal-title":"Int J Obes Suppl"},{"issue":"10","key":"1194_CR39","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/sj.ijo.0802079","volume":"26","author":"O Della-Zuana","year":"2002","unstructured":"Della-Zuana O, Presse F, Ortola C, Duhault J, Nahon JL, Levens N (2002) Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats. Int J Obes Relat Metab Disord 26(10):1289\u20131295. \n                    https:\/\/doi.org\/10.1038\/sj.ijo.0802079","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"12","key":"1194_CR40","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0196-9781(99)00164-3","volume":"20","author":"ME Monzon","year":"1999","unstructured":"Monzon ME, de Souza MM, Izquierdo LA, Izquierdo I, Barros DM, de Barioglio SR (1999) Melanin-concentrating hormone (MCH) modifies memory retention in rats. Peptides 20(12):1517\u20131519","journal-title":"Peptides"},{"key":"1194_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnsys.2017.00032","volume":"11","author":"GB Diniz","year":"2017","unstructured":"Diniz GB, Bittencourt JC (2017) The melanin-concentrating hormone as an integrative peptide driving motivated behaviors. Front Syst Neurosci 11:32. \n                    https:\/\/doi.org\/10.3389\/fnsys.2017.00032","journal-title":"Front Syst Neurosci"},{"issue":"8","key":"1194_CR42","doi-asserted-by":"publisher","first-page":"e103585","DOI":"10.1371\/journal.pone.0103585","volume":"9","author":"N Li","year":"2014","unstructured":"Li N, Nattie E, Li A (2014) The role of melanin concentrating hormone (MCH) in the central chemoreflex: a knockdown study by siRNA in the lateral hypothalamus in rats. PLoS One 9(8):e103585. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0103585","journal-title":"PLoS One"},{"key":"1194_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbr.2013.05.006","volume":"250","author":"LI Serova","year":"2013","unstructured":"Serova LI, Laukova M, Alaluf LG, Sabban EL (2013) Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress. Behav Brain Res 250:139\u2013147. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2013.05.006","journal-title":"Behav Brain Res"},{"issue":"3","key":"1194_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.biopsych.2007.12.011","volume":"64","author":"P Pissios","year":"2008","unstructured":"Pissios P, Frank L, Kennedy AR, Porter DR, Marino FE, Liu FF, Pothos EN, Maratos-Flier E (2008) Dysregulation of the mesolimbic dopamine system and reward in MCH-\/- mice. Biol Psychiatry 64(3):184\u2013191. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2007.12.011","journal-title":"Biol Psychiatry"},{"issue":"16","key":"1194_CR45","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1073\/pnas.0811331106","volume":"106","author":"S Chung","year":"2009","unstructured":"Chung S, Hopf FW, Nagasaki H, Li CY, Belluzzi JD, Bonci A, Civelli O (2009) The melanin-concentrating hormone system modulates cocaine reward. Proc Natl Acad Sci U S A 106(16):6772\u20136777. \n                    https:\/\/doi.org\/10.1073\/pnas.0811331106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1194_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/SAR.S70350","volume":"6","author":"AJ Sandweiss","year":"2015","unstructured":"Sandweiss AJ, Vanderah TW (2015) The pharmacology of neurokinin receptors in addiction: prospects for therapy. Subst Abuse Rehabil 6:93\u2013102. \n                    https:\/\/doi.org\/10.2147\/SAR.S70350","journal-title":"Subst Abuse Rehabil"},{"key":"1194_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuroscience.2011.12.018","volume":"203","author":"K Misono","year":"2012","unstructured":"Misono K, Lessard A (2012) Apomorphine-evoked redistribution of neurokinin-3 receptors in dopaminergic dendrites and neuronal nuclei of the rat ventral tegmental area. Neuroscience 203:27\u201338. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2011.12.018","journal-title":"Neuroscience"},{"issue":"1","key":"1194_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0014-2999(92)90251-X","volume":"213","author":"P Overton","year":"1992","unstructured":"Overton P, Elliott PJ, Hagan RM, Clark D (1992) Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Eur J Pharmacol 213(1):165\u2013166","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1194_CR49","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.neuropharm.2008.03.005","volume":"54","author":"X Zhang","year":"2008","unstructured":"Zhang X, Andren PE, Chergui K, Svenningsson P (2008) Neurokinin B\/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson\u2019s disease. Neuropharmacology 54(7):1143\u20131152. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2008.03.005","journal-title":"Neuropharmacology"},{"key":"1194_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.06.005","volume":"131","author":"AC Ferreira","year":"2015","unstructured":"Ferreira AC, Da Mesquita S, Sousa JC, Correia-Neves M, Sousa N, Palha JA, Marques F (2015) From the periphery to the brain: lipocalin-2, a friend or foe? Prog Neurobiol 131:120\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2015.06.005","journal-title":"Prog Neurobiol"},{"issue":"20","key":"1194_CR51","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1523\/JNEUROSCI.4261-15.2016","volume":"36","author":"BW Kim","year":"2016","unstructured":"Kim BW, Jeong KH, Kim JH, Jin M, Lee MG, Choi DK, Won SY, McLean C et al (2016) Pathogenic upregulation of glial lipocalin-2 in the parkinsonian dopaminergic system. J Neurosci 36(20):5608\u20135622. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4261-15.2016","journal-title":"J Neurosci"},{"issue":"7","key":"1194_CR52","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/STROKEAHA.114.005733","volume":"45","author":"C Xing","year":"2014","unstructured":"Xing C, Wang X, Cheng C, Montaner J, Mandeville E, Leung W, van Leyen K, Lok J et al (2014) Neuronal production of lipocalin-2 as a help-me signal for glial activation. Stroke 45(7):2085\u20132092. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.005733","journal-title":"Stroke"},{"issue":"2","key":"1194_CR53","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/mp.2016.243","volume":"23","author":"S S Kang","year":"2017","unstructured":"Kang SS, Ren Y, Liu CC, Kurti A, Baker KE, Bu G, Asmann Y, Fryer JD (2017) Lipocalin-2 protects the brain during inflammatory conditions. Mol Psychiatry. \n                    https:\/\/doi.org\/10.1038\/mp.2016.243","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"1194_CR54","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1124\/jpet.105.091512","volume":"320","author":"A Vicentic","year":"2007","unstructured":"Vicentic A, Jones DC (2007) The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. J Pharmacol Exp Ther 320(2):499\u2013506. \n                    https:\/\/doi.org\/10.1124\/jpet.105.091512","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1194_CR55","doi-asserted-by":"publisher","first-page":"e29343","DOI":"10.1371\/journal.pone.0029343","volume":"7","author":"P Mao","year":"2012","unstructured":"Mao P, Meshul CK, Thuillier P, Goldberg NR, Reddy PH (2012) CART peptide is a potential endogenous antioxidant and preferentially localized in mitochondria. PLoS One 7(1):e29343. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0029343","journal-title":"PLoS One"},{"issue":"1","key":"1194_CR56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/ph6010108","volume":"6","author":"P Mao","year":"2013","unstructured":"Mao P, Meshul CK, Thuillier P, Reddy PH (2013) Neurotransmitter CART as a new therapeutic candidate for Parkinson\u2019s disease. Pharmaceuticals (Basel) 6(1):108\u2013123. \n                    https:\/\/doi.org\/10.3390\/ph6010108","journal-title":"Pharmaceuticals (Basel)"},{"key":"1194_CR57","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bbr.2015.12.031","volume":"301","author":"MA Upadhya","year":"2016","unstructured":"Upadhya MA, Shelkar GP, Subhedar NK, Kokare DM (2016) CART modulates the effects of levodopa in rat model of Parkinson\u2019s disease. Behav Brain Res 301:262\u2013272. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2015.12.031","journal-title":"Behav Brain Res"},{"issue":"5","key":"1194_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jpain.2014.01.498","volume":"15","author":"JY Park","year":"2014","unstructured":"Park JY, Park JJ, Jeon S, Doo AR, Kim SN, Lee H, Chae Y, Maixner W et al (2014) From peripheral to central: the role of ERK signaling pathway in acupuncture analgesia. J Pain 15(5):535\u2013549. \n                    https:\/\/doi.org\/10.1016\/j.jpain.2014.01.498","journal-title":"J Pain"},{"key":"1194_CR59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","volume":"132","author":"MF Bastide","year":"2015","unstructured":"Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C et al (2015) Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson\u2019s disease. Prog Neurobiol 132:96\u2013168. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2015.07.002","journal-title":"Prog Neurobiol"},{"issue":"9","key":"1194_CR60","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrn2471","volume":"9","author":"P Jenner","year":"2008","unstructured":"Jenner P (2008) Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 9(9):665\u2013677. \n                    https:\/\/doi.org\/10.1038\/nrn2471","journal-title":"Nat Rev Neurosci"},{"key":"1194_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.expneurol.2017.04.011","volume":"294","author":"M Alam","year":"2017","unstructured":"Alam M, Rumpel R, Jin X, von Wrangel C, Tschirner SK, Krauss JK, Grothe C, Ratzka A et al (2017) Altered somatosensory cortex neuronal activity in a rat model of Parkinson\u2019s disease and levodopa-induced dyskinesias. Exp Neurol 294:19\u201331. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2017.04.011","journal-title":"Exp Neurol"},{"key":"1194_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2013.09.020","volume":"62","author":"MF Bastide","year":"2014","unstructured":"Bastide MF, Dovero S, Charron G, Porras G, Gross CE, Fernagut PO, Bezard E (2014) Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia. Neurobiol Dis 62:179\u2013192. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2013.09.020","journal-title":"Neurobiol Dis"},{"issue":"Pt 2","key":"1194_CR63","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/brain\/awu329","volume":"138","author":"A Cerasa","year":"2015","unstructured":"Cerasa A, Koch G, Donzuso G, Mangone G, Morelli M, Brusa L, Stampanoni Bassi M, Ponzo V et al (2015) A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. Brain 138(Pt 2):414\u2013427. \n                    https:\/\/doi.org\/10.1093\/brain\/awu329","journal-title":"Brain"},{"issue":"30","key":"1194_CR64","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1073\/pnas.0804536105","volume":"105","author":"E Kokkotou","year":"2008","unstructured":"Kokkotou E, Moss AC, Torres D, Karagiannides I, Cheifetz A, Liu S, O\u2019Brien M, Maratos-Flier E et al (2008) Melanin-concentrating hormone as a mediator of intestinal inflammation. Proc Natl Acad Sci U S A 105(30):10613\u201310618. \n                    https:\/\/doi.org\/10.1073\/pnas.0804536105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1194_CR65","doi-asserted-by":"publisher","first-page":"e41914","DOI":"10.1371\/journal.pone.0041914","volume":"7","author":"JM Nagel","year":"2012","unstructured":"Nagel JM, Geiger BM, Karagiannis AK, Gras-Miralles B, Horst D, Najarian RM, Ziogas DC, Chen X et al (2012) Reduced intestinal tumorigenesis in APCmin mice lacking melanin-concentrating hormone. PLoS One 7(7):e41914. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0041914","journal-title":"PLoS One"},{"issue":"1","key":"1194_CR66","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1128\/IAI.00572-12","volume":"81","author":"AK Karagiannis","year":"2013","unstructured":"Karagiannis AK, Ziogas DC, Gras-Miralles B, Geiger BM, Nagel J, Trebicka E, Najarian R, Cherayil BJ et al (2013) Increased susceptibility of melanin-concentrating hormone-deficient mice to infection with Salmonella enterica serovar typhimurium. Infect Immun 81(1):166\u2013172. \n                    https:\/\/doi.org\/10.1128\/IAI.00572-12","journal-title":"Infect Immun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1194-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1194-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1194-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T08:40:58Z","timestamp":1569228058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1194-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1194-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"3 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}